Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ)
CNY 14.16
(1.58%)
CNY 14.16
(1.58%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 652.48 Million CNY | 120.21% |
| 2022 | 296.29 Million CNY | 75.89% |
| 2021 | 168.45 Million CNY | -43.99% |
| 2020 | 300.77 Million CNY | -16.31% |
| 2019 | 359.4 Million CNY | 139.6% |
| 2018 | 150 Million CNY | -19.17% |
| 2017 | 185.56 Million CNY | -7.22% |
| 2016 | 200 Million CNY | 285.82% |
| 2015 | 51.83 Million CNY | 32.39% |
| 2014 | 39.15 Million CNY | -71.22% |
| 2013 | 136.03 Million CNY | -39.93% |
| 2012 | 226.44 Million CNY | -14.67% |
| 2011 | 265.36 Million CNY | -30.89% |
| 2010 | 383.95 Million CNY | 22.95% |
| 2009 | 312.3 Million CNY | -21.53% |
| 2008 | 398 Million CNY | 2.05% |
| 2007 | 390 Million CNY | 68.47% |
| 2006 | 231.5 Million CNY | 75.3% |
| 2005 | 132.05 Million CNY | 102.99% |
| 2004 | 65.05 Million CNY | -27.76% |
| 2003 | 90.05 Million CNY | 45.75% |
| 2002 | 61.78 Million CNY | 77.8% |
| 2001 | 34.75 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 352 Million CNY | -57.02% |
| 2024 Q2 | 874.97 Million CNY | 133.95% |
| 2024 Q1 | 373.99 Million CNY | -42.68% |
| 2023 FY | 652.48 Million CNY | 120.21% |
| 2023 Q2 | 409.08 Million CNY | 44.88% |
| 2023 Q3 | 408.64 Million CNY | -0.11% |
| 2023 Q1 | 282.35 Million CNY | -4.7% |
| 2023 Q4 | 652.48 Million CNY | 59.67% |
| 2022 Q2 | 268.05 Million CNY | 41.63% |
| 2022 Q1 | 189.26 Million CNY | 12.35% |
| 2022 FY | 296.29 Million CNY | 75.89% |
| 2022 Q4 | 296.29 Million CNY | 8.02% |
| 2022 Q3 | 274.28 Million CNY | 2.32% |
| 2021 Q4 | 168.45 Million CNY | 40.81% |
| 2021 FY | 168.45 Million CNY | -43.99% |
| 2021 Q1 | 23.1 Million CNY | -92.32% |
| 2021 Q2 | 122.25 Million CNY | 429.09% |
| 2021 Q3 | 119.63 Million CNY | -2.14% |
| 2020 Q2 | 450.78 Million CNY | -9.99% |
| 2020 FY | 300.77 Million CNY | -16.31% |
| 2020 Q1 | 500.81 Million CNY | 39.34% |
| 2020 Q4 | 300.77 Million CNY | -14.24% |
| 2020 Q3 | 350.73 Million CNY | -22.2% |
| 2019 FY | 359.4 Million CNY | 139.6% |
| 2019 Q4 | 359.4 Million CNY | 15.64% |
| 2019 Q1 | 255.88 Million CNY | 70.59% |
| 2019 Q2 | 360.79 Million CNY | 41.0% |
| 2019 Q3 | 310.8 Million CNY | -13.86% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 150 Million CNY | -19.17% |
| 2018 Q3 | 150 Million CNY | 0.0% |
| 2018 Q4 | 150 Million CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q1 | 200 Million CNY | 0.0% |
| 2017 Q4 | - CNY | -100.0% |
| 2017 FY | 185.56 Million CNY | -7.22% |
| 2017 Q3 | 50 Million CNY | -75.0% |
| 2017 Q2 | 200 Million CNY | 0.0% |
| 2016 FY | 200 Million CNY | 285.82% |
| 2016 Q3 | 1 Million CNY | -98.89% |
| 2016 Q2 | 90 Million CNY | -10.5% |
| 2016 Q1 | 100.56 Million CNY | 93.99% |
| 2016 Q4 | 200 Million CNY | 19900.0% |
| 2015 Q3 | 14.32 Million CNY | -1.73% |
| 2015 Q4 | 51.83 Million CNY | 261.76% |
| 2015 FY | 51.83 Million CNY | 32.39% |
| 2015 Q1 | 17.77 Million CNY | -54.61% |
| 2015 Q2 | 14.58 Million CNY | -17.95% |
| 2014 Q4 | 39.15 Million CNY | 830.63% |
| 2014 Q2 | 20.67 Million CNY | -83.51% |
| 2014 Q1 | 125.35 Million CNY | -7.86% |
| 2014 FY | 39.15 Million CNY | -71.22% |
| 2014 Q3 | 4.2 Million CNY | -79.65% |
| 2013 Q1 | 232.51 Million CNY | 2.68% |
| 2013 Q2 | 280.71 Million CNY | 20.73% |
| 2013 Q3 | 160.23 Million CNY | -42.92% |
| 2013 Q4 | 136.03 Million CNY | -15.1% |
| 2013 FY | 136.03 Million CNY | -39.93% |
| 2012 Q3 | 206.67 Million CNY | -9.18% |
| 2012 Q1 | 254.47 Million CNY | -4.11% |
| 2012 FY | 226.44 Million CNY | -14.67% |
| 2012 Q4 | 226.44 Million CNY | 9.57% |
| 2012 Q2 | 227.57 Million CNY | -10.57% |
| 2011 Q3 | 441.75 Million CNY | 2.94% |
| 2011 Q1 | 400.06 Million CNY | 4.19% |
| 2011 FY | 265.36 Million CNY | -30.89% |
| 2011 Q2 | 429.14 Million CNY | 7.27% |
| 2011 Q4 | 265.36 Million CNY | -39.93% |
| 2010 Q1 | 298.3 Million CNY | -4.48% |
| 2010 FY | 383.95 Million CNY | 22.95% |
| 2010 Q4 | 383.95 Million CNY | 7.25% |
| 2010 Q3 | 358 Million CNY | 2.78% |
| 2010 Q2 | 348.3 Million CNY | 16.76% |
| 2009 Q2 | 374 Million CNY | -2.6% |
| 2009 Q3 | 342.3 Million CNY | -8.48% |
| 2009 Q4 | 312.3 Million CNY | -8.76% |
| 2009 FY | 312.3 Million CNY | -21.53% |
| 2009 Q1 | 384 Million CNY | -3.52% |
| 2008 Q2 | 385.5 Million CNY | 1.45% |
| 2008 Q1 | 380 Million CNY | -2.56% |
| 2008 FY | 398 Million CNY | 2.05% |
| 2008 Q4 | 398 Million CNY | -1.24% |
| 2008 Q3 | 403 Million CNY | 4.54% |
| 2007 Q4 | 390 Million CNY | 15.9% |
| 2007 Q3 | 336.5 Million CNY | 15.44% |
| 2007 Q2 | 291.5 Million CNY | 23.26% |
| 2007 Q1 | 236.5 Million CNY | 2.16% |
| 2007 FY | 390 Million CNY | 68.47% |
| 2006 Q1 | 181.05 Million CNY | 37.1% |
| 2006 Q3 | 218.5 Million CNY | 4.8% |
| 2006 Q2 | 208.5 Million CNY | 15.16% |
| 2006 Q4 | 231.5 Million CNY | 5.95% |
| 2006 FY | 231.5 Million CNY | 75.3% |
| 2005 Q4 | 132.05 Million CNY | 43.45% |
| 2005 Q3 | 92.05 Million CNY | 0.0% |
| 2005 Q2 | 92.05 Million CNY | 0.0% |
| 2005 FY | 132.05 Million CNY | 102.99% |
| 2005 Q1 | 92.05 Million CNY | 41.5% |
| 2004 Q4 | 65.05 Million CNY | 3.18% |
| 2004 FY | 65.05 Million CNY | -27.76% |
| 2004 Q2 | 103.05 Million CNY | 0.0% |
| 2004 Q3 | 63.05 Million CNY | -38.81% |
| 2003 Q4 | 90.05 Million CNY | 0.0% |
| 2003 FY | 90.05 Million CNY | 45.75% |
| 2002 FY | 61.78 Million CNY | 77.8% |
| 2001 FY | 34.75 Million CNY | 0.0% |